Liquid Biopsies – News and Features

News
Blood Test Identifies Hard-To-Detect Pancreatic Cancer With 85% Accuracy
Scientists at Oregon Health & Science University developed PAC-MANN, a blood test that detects pancreatic cancer with 98% accuracy. The test identifies protease activity linked to tumors, allowing earlier detection and tracking of treatment response.

News
Blood Test May Guide Anti-Inflammatory Drug Use To Reduce Colon Cancer Risk
A study finds that celecoxib improves disease-free survival in stage 3 colon cancer patients with positive ctDNA after surgery. The analysis highlights ctDNA’s predictive role in identifying patients who may benefit from anti-inflammatory drugs.

Article
Key Strategies for Optimizing NGS Workflows
In this article, Momin Shah discusses how to ensure that NGS protocols are optimized from the outset to save time and costs on new research projects.

Article
The Impact of Functional Genomics in Drug Discovery
Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and progressing understanding of existing drugs.

News
Preventing Cancer Metastases With Cardiac Drug
Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases formation.

News
Machine Learning-Powered Blood Test Enables Detection of Multiple Cancers
A new machine learning-powered blood test can detect multiple types of cancer in their earliest stages.

News
New ctDNA Test Predicts Lung Cancer Relapse Risk and Survival
A study finds that a sensitive test detecting circulating tumour DNA (ctDNA) in early-stage lung cancer can predict relapse risk and survival. This approach could help doctors personalize treatment and improve patient outcomes.

News
40% Drop in Lung Cancer Deaths Using Biomarker Testing Trial
A study has demonstrated that biomarker testing in smokers and ex-smokers can reduce lung cancer deaths by 40%. This large-scale trial highlights how measurable biological indicators enable earlier detection of lung cancer, improving survival rates.

News
Study Detects Cancer Cells With Biolasers
University of Michigan researchers developed a biolaser-based method to detect circulating tumor cells in pancreatic and lung cancer patients. By combining cell lasers with machine learning, the technique identifies tumor cells with 99% accuracy.

News
Researchers Produce Mini-Tumors From Circulating Cancer Cells
For the first time, researchers have cultivated stable tumor organoids from circulating breast cancer cells, improving research into therapy resistance.
Advertisement